Overview
Phillip Scheinberg is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Scheinberg has been practicing medicine for over 21 years and is rated as an Elite provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, and Bone Marrow Transplant.
His clinical research consists of co-authoring 92 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles in the study of Paroxysmal Nocturnal Hemoglobinuria (PNH).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Clara Chan is a Hematologist Oncology specialist and a Hematologist in Silver Spring, Maryland. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Her top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Febrile Neutropenia, Chronic Familial Neutropenia, Osteotomy, and Bone Graft. Dr. Chan is currently accepting new patients.
Privia Medical Group, LLC
Henry Fox is a Hematologist Oncology specialist and a Hematologist in Chevy Chase, Maryland. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Antiphospholipid Syndrome, Glossitis, and Pernicious Anemia. Dr. Fox is currently accepting new patients.
University Of Maryland Oncology Associates PA
Maria Baer is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Baer is rated as an Elite provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Splenectomy. Dr. Baer is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AnemiaDr. Scheinberg isElite. Learn about Anemia.
- Aplastic AnemiaDr. Scheinberg isElite. Learn about Aplastic Anemia.
- Paroxysmal Cold HemoglobinuriaDr. Scheinberg isElite. Learn about Paroxysmal Cold Hemoglobinuria.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Distinguished
- HemolysisDr. Scheinberg isDistinguished. Learn about Hemolysis.
- Hemolytic AnemiaDr. Scheinberg isDistinguished. Learn about Hemolytic Anemia.
- Advanced
- Myelodysplastic Syndrome (MDS)Dr. Scheinberg isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Bone Marrow TransplantDr. Scheinberg isExperienced. Learn about Bone Marrow Transplant.
- Chromosome 8p DeletionDr. Scheinberg isExperienced. Learn about Chromosome 8p Deletion.
- Follicular LymphomaDr. Scheinberg isExperienced. Learn about Follicular Lymphoma.
- Graft Versus Host Disease (GvHD)Dr. Scheinberg isExperienced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaDr. Scheinberg isExperienced. Learn about Leukemia.
- Marginal Zone Lymphoma (MZL)Dr. Scheinberg isExperienced. Learn about Marginal Zone Lymphoma (MZL).